This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pathway

Authoring team

The pathway of cellular respiration by glycolysis can be considered firstly in terms of:

  • entry of glucose into the cell or
  • production of glucose from another source e.g. glycogen, galactose

Then, there are the sequential enzyme reactions:

  • hexokinase converts glucose into glucose-6-phosphate
  • glucose-6-phosphate isomerase converts glucose-6-phosphate into fructose-6-phosphate
  • 6-phosphofructokinase converts fructose-6-phosphate into fructose-1,6-biphosphate
  • fructose biphosphate aldolase converts fructose-1,6-biphosphate into glyceraldehyde-3-phosphate and dihydroxyacetone phosphate
  • triose phosphate isomerase converts dihydroxyacetone phosphate into glyceraldehyde-3-phosphate
  • glyceraldehyde phosphate dehydrogenase converts glyceraldehyde-3-phosphate into 3-phosphoglyceroyl phosphate
  • phosphoglycerate kinase converts 3-phosphoglyceroyl phosphate into 3-phosphoglycerate
  • phosphoglycerol mutase converts 3-phosphoglycerate into 2-phosphoglycerate
  • enolase converts 2-phosphoglycerate into phosphoenolpyruvate
  • pyruvate kinase converts phosphoenolpyruvate into pyruvate

Following glycolysis, one of the following two forward reactions may occur:

  • pyruvate dehydrogenase converts pyruvate into acetyl CoA
  • lactate dehydrogenase converts pyruvate into lactate - anaerobic glycolysis

Individual enzymes are considered in the submenu.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.